Endothelial cell activation is attenuated by everolimus via transcriptional and post-transcriptional regulatory mechanisms after drug-eluting coronary stenting.
We previously found higher level of endothelial cell (EC) activation in patients who suffered from in-stent restenosis after bare-metal stenting compared to subjects who underwent drug-eluting stenting (DES) showing no complications. Here we investigated the potential transcriptional and post-transc...
Saved in:
Similar Items
-
Prolyl Hydroxylase Inhibitor-Mediated HIF Activation Drives Transcriptional Reprogramming in Retinal Pigment Epithelium: Relevance to Chronic Kidney Disease
by: Tamás Gáll, et al.
Published: (2025-07-01) -
Epigenomic preconditioning of peripheral monocytes determines their transcriptional response to the tumor microenvironment
by: Máté Kiss, et al.
Published: (2025-07-01) -
Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.
by: Da Hyon Lee, et al.
Published: (2017-01-01) -
Comparison of the Efficacy of Everolimus-Eluting Stents and Paclitaxel-Eluting Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis
by: Zhili Wei, et al.
Published: (2025-06-01) -
Fabrication of a 3D printed everolimus-eluting stent made of thermoplastic polyurethane and polylactide
by: M. T. Bekov, et al.
Published: (2024-04-01)